[ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy].
作者信息
Fabian Alexander, Nicolay Nils H, Krug David
机构信息
Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Deutschland.
Klinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland.
出版信息
Strahlenther Onkol. 2022 Nov;198(11):1045-1048. doi: 10.1007/s00066-022-01987-2. Epub 2022 Aug 1.
Abstract
摘要
相似文献
1
[ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy].[ORATOR2试验：在降阶梯治疗背景下，HPV相关口咽癌的原发手术与原发放疗的随机对照研究]
Strahlenther Onkol. 2022 Nov;198(11):1045-1048. doi: 10.1007/s00066-022-01987-2. Epub 2022 Aug 1.
2
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.评估 HPV 相关口咽鳞状细胞癌放疗降阶梯治疗与经口手术治疗的毒性效应和生存情况：ORATOR2 期随机临床试验。
JAMA Oncol. 2022 Jun 1;8(6):1-7. doi: 10.1001/jamaoncol.2022.0615.
3
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.HPV 相关口咽鳞状细胞癌放疗与经口手术降阶梯治疗（ORATOR2）：一项随机 II 期试验的研究方案。
BMC Cancer. 2020 Feb 14;20(1):125. doi: 10.1186/s12885-020-6607-z.
4
Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer.早期人乳头瘤病毒阳性口咽癌的放疗与手术对比
Cancer Res Treat. 2022 Apr;54(2):406-416. doi: 10.4143/crt.2021.441. Epub 2021 Jun 23.
5
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm.人乳头瘤病毒相关口咽癌的治疗减强度：一种确定性手术模式。
Semin Radiat Oncol. 2021 Oct;31(4):332-338. doi: 10.1016/j.semradonc.2021.07.001.
6
Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.优化头颈部癌症的降阶梯治疗：现状与未来展望。
Oncologist. 2021 Jan;26(1):40-48. doi: 10.1634/theoncologist.2020-0303. Epub 2020 Sep 21.
7
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.结外侵犯在人乳头瘤病毒相关口咽鳞状细胞癌中的预后价值。
Cancer. 2017 Jul 15;123(14):2762-2772. doi: 10.1002/cncr.30598. Epub 2017 Mar 21.
8
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.质子治疗头颈部 HPV 相关口咽癌：一种减毒策略。
Curr Treat Options Oncol. 2021 Jun 4;22(6):54. doi: 10.1007/s11864-021-00847-y.
9
Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review protocol.人乳头瘤病毒相关性口咽鳞状细胞癌患者接受低剂量与标准剂量放疗对生存和放射性相关毒性影响的系统评价方案。
JBI Evid Synth. 2022 Apr 1;20(4):1135-1141. doi: 10.11124/JBIES-21-00159.
10
A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.人乳头瘤病毒阳性口咽鳞状细胞癌基于风险和策略调整的降阶梯治疗方案
Cancer. 2021 Dec 1;127(23):4330-4338. doi: 10.1002/cncr.33851. Epub 2021 Aug 11.
引用本文的文献
1
Financial toxicity amongst cancer patients and survivors: a comparative study of the United Kingdom and United States.癌症患者及幸存者中的经济毒性：英国与美国的比较研究
Support Care Cancer. 2025 May 31;33(6):521. doi: 10.1007/s00520-025-09568-6.
2
[Long-term results of the ORATOR-study: radiotherapy versus transoral robotic surgery for oropharyngeal cancer].ORATOR研究的长期结果：口咽癌的放射治疗与经口机器人手术对比
Strahlenther Onkol. 2025 Feb;201(2):201-203. doi: 10.1007/s00066-024-02335-2. Epub 2024 Dec 9.
3
Meningioma WHO I with involvement of the optical structures-does proton therapy lead to changes in quality of life with regard to subjective visual performance?WHO 一级脑膜瘤累及视结构-质子治疗是否会导致主观视觉表现方面的生活质量变化？
Strahlenther Onkol. 2023 Apr;199(4):404-411. doi: 10.1007/s00066-022-02024-y. Epub 2022 Dec 5.
本文引用的文献
1
The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.手术可切除性对人乳头瘤病毒相关口咽癌行单纯放疗患者结局的影响。
Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):521-529. doi: 10.1016/j.ijrobp.2022.02.025. Epub 2022 Feb 26.
2
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.随机对照试验：放疗对比经口机器人手术治疗口咽鳞癌：ORATOR 试验的长期结果。
J Clin Oncol. 2022 Mar 10;40(8):866-875. doi: 10.1200/JCO.21.01961. Epub 2022 Jan 7.
3
Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.经口机器人手术在口咽癌治疗中的应用与安全性。
Cancer. 2022 Feb 15;128(4):685-696. doi: 10.1002/cncr.33995. Epub 2021 Nov 11.
4
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).可切除 p16+局部晚期口咽癌的经口手术联合低剂量调强放疗的 II 期随机试验：一项 ECOG-ACRIN 癌症研究组试验（E3311）。
J Clin Oncol. 2022 Jan 10;40(2):138-149. doi: 10.1200/JCO.21.01752. Epub 2021 Oct 26.
5
De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond.头颈部鳞状细胞癌（化疗）放疗的降阶梯策略——人乳头瘤病毒及其他情况
Cancers (Basel). 2021 May 4;13(9):2204. doi: 10.3390/cancers13092204.
6
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).HPV 相关口咽癌的低剂量放疗（NRG 肿瘤学 HN002）。
J Clin Oncol. 2021 Mar 20;39(9):956-965. doi: 10.1200/JCO.20.03128. Epub 2021 Jan 28.
7
Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.优化头颈部癌症的降阶梯治疗：现状与未来展望。
Oncologist. 2021 Jan;26(1):40-48. doi: 10.1634/theoncologist.2020-0303. Epub 2020 Sep 21.
8
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.HPV 相关口咽鳞状细胞癌放疗与经口手术降阶梯治疗（ORATOR2）：一项随机 II 期试验的研究方案。
BMC Cancer. 2020 Feb 14;20(1):125. doi: 10.1186/s12885-020-6607-z.
9
[Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides].[放射治疗与经口机器人手术治疗口咽鳞状细胞癌的初步治疗：随机化决定]
Strahlenther Onkol. 2020 Feb;196(2):202-204. doi: 10.1007/s00066-019-01567-x.
10
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.放疗与经口机器人手术和颈部清扫术治疗口咽鳞状细胞癌（ORATOR）：一项开放标签、2 期、随机试验。
Lancet Oncol. 2019 Oct;20(10):1349-1359. doi: 10.1016/S1470-2045(19)30410-3. Epub 2019 Aug 12.
Zotero 插件